Brain-Inspired ‘Memtransistor’ Chip Detects Cardiac Arrhythmias in a Fraction of a Second

EVANSTON, Ill. — Researchers at Northwestern University have engineered a novel, brain-inspired microchip capable of identifying abnormal heart rhythms in electrocardiogram (ECG) data with more than 98% accuracy. Crucially, the prototype accomplishes this feat while consuming roughly 10,000 times fewer computing operations than traditional artificial intelligence (AI) algorithms, pointing toward a future generation of ultra-low-power, “always-on” medical wearables.

The study, published in Nature Communications on July 10, 2026, introduces a hardware breakthrough designed to mimic the human cerebellum—the brain region responsible for rapid, reflex-like responses and detecting unexpected shifts in bodily motion or sensory input.

Re-Engineering AI for Efficiency: The Cerebellum Model

Modern consumer wearables like smartwatches can already spot irregular heart rhythms, but their internal algorithms usually rely on energy-intensive deep learning models. These conventional AI systems continuously crunch heavy streams of numerical data, analyzing every single waveform sample regardless of whether the heart is beating normally. This continuous processing drains battery power rapidly, often requiring daily device recharges that leave gaps in long-term cardiac monitoring.

To solve this efficiency bottleneck, the Northwestern research team designed a neuromorphic (brain-like) circuit called a memtransistor—a hybrid electronic component that combines memory storage and signal processing on a single nanoscale device.

Instead of crunching raw numbers nonstop, the chip operates on an “event-driven” principle:

• Passive Surveillance Mode: While the heartbeat remains steady and predictable, the chip remains in a low-power monitoring state, consuming negligible energy.

• Rapid Novelty Detection: The moment an unexpected variation or anomaly appears in the electrical signal, the chip instantly triggers an active analysis mode.

In proof-of-concept testing, the hardware identified irregular cardiac rhythms in real time—flagging the anomaly before the single cardiac cycle had even fully completed.

“The system detected an irregular heartbeat in a fraction of a second, before the heartbeat had even finished,” noted Mark C. Hersam, Ph.D., lead researcher on the project and professor of materials science and engineering at Northwestern University.

This speed is directly tied to the architecture: by eliminating the need to send data back and forth between separate memory units and processors—a bottleneck in standard computer chips—the chip processes biosignals almost instantaneously at the hardware level.

Why Rapid Detection Matters: The Clinical Stake of Arrhythmias

Cardiac arrhythmias occur when the electrical signals coordinating heartbeats fail to function properly, causing the heart to beat too fast, too slow, or irregularly.

The most common clinically treated arrhythmia is atrial fibrillation (AFib), a condition characterized by rapid, chaotic quivering in the heart’s upper chambers. According to data from the Centers for Disease Control and Prevention (CDC):

• Asymptomatic Risk: AFib often presents without noticeable symptoms, leaving many individuals unaware of their condition until a severe medical event occurs.

• Stroke Prevalence: People with AFib face approximately a fivefold increased risk of ischemic stroke compared to those without the condition, even after adjusting for traditional cardiovascular risk factors.

• Healthcare Impact: AFib contributes to hundreds of thousands of hospitalizations and tens of thousands of deaths annually in the United States alone.

Because arrhythmias can occur sporadically—lasting only a few seconds before returning to a normal sinus rhythm—catching them requires continuous observation. A sensor that can run for weeks or months without exhausting its battery could significantly improve detection rates for silent AFib, enabling earlier medical intervention and preventative stroke therapy.

Technical Limitations and the Path to Clinical Adoption

While the study’s findings represent a significant leap in hardware design, independent medical experts emphasize that the research remains in its early stages.

The chip’s design reproduces a specific subset of cerebellar function—namely, automated novelty detection—rather than replicating the entire organ’s complex neural network. Furthermore, the 98% accuracy rate was achieved in controlled, laboratory proof-of-concept tests using pre-recorded ECG datasets, rather than live human trials.

Translating a promising benchtop prototype into a certified medical device involves several key hurdles:

1. Real-World Artifact Noise: In everyday life, wearable devices encounter significant signal noise caused by muscle movement, loose skin contact, or environmental electromagnetic interference. The hardware must prove it can distinguish true cardiac anomalies from motion artifacts without triggering excessive false alarms.

2. Clinical Validation: Large-scale prospective clinical trials comparing the memtransistor against gold-standard Holter monitors or implantable loop recorders will be necessary before healthcare providers can rely on the tech for diagnostic decision-making.

3. Manufacturing & Scalability: The authors have filed a provisional patent for the technology, indicating commercial interest, but mass-producing specialized nanoelectronic memtransistors reliably and cost-effectively remains an engineering challenge.

What This Means for Patients and Consumers

For patients currently managing heart conditions or consumers interested in health tracking, this research signals an evolving trend toward smarter, less obtrusive health monitors. However, clinicians caution against relying solely on consumer technology for heart health.

If you experience symptoms such as heart palpitations, unexpected dizziness, shortness of breath, or chest discomfort, you should seek direct medical evaluation rather than waiting for a wearable device to issue a warning. Conversely, an alert from a smartwatch or patch should always be confirmed by a healthcare professional using standard diagnostic tools like a 12-lead ECG.

Looking further ahead, ultra-low-power neuromorphic chips could extend far beyond consumer smartwatches. They hold potential for implantable cardiac monitors, continuous glucose sensors, and smart patches deployed in low-resource or remote clinical settings where frequent battery replacement or continuous grid power is impractical.

Reference Section

• https://www.earth.com/news/brain-inspired-chip-detects-abnormal-heartbeats-almost-instantly/

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.